José Antonio Sanches, MD, PhD is an expert in Dermatology at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (Brazil). As of October 2026, ScienceLeadR ranks José Antonio Sanches in the top 1% of experts in Brazil for Lymphoma and Lymphoproliferative Disorders. José Antonio Sanches has authored 169 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 564 (community average: 125). How the SLR is computed.

LeadR Profile

564 ScienceLeadR Reputation 564
Network Map

Dermatology

Subspecialties: Hematology - Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2011 - 2026

Source: PubMed

Universidade de São Paulo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 169

Citations

Citations: 4 368 1st author: 6 Last author: 70 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Expert consensus on the management of peripheral neuropathy in patients with lymphoma on brentuximab vedotin.
PMID 42891686 — peripheral nervous system diseases, brentuximab vedotin, pharmaceutical preparations, lymphoma, therapeutics, palliative care
Support Care Cancer20260
Cutaneous Lymphoma International Prognostic Index and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome.
PMID 42842270 — mycosis fungoides, sezary syndrome, lymphoma, disease progression, skin diseases, diagnosis
JAMA Dermatol20261
Comment on 'Context, not class, may be the key signal in systemic JAK inhibitor exposure in MF/SS': reply from authors.
PMID 42287026 — syphilis, janus kinase inhibitors, dermatology
Br J Dermatol20260
Epigenetic dysregulation in mycosis fungoides and sézary syndrome.
PMID 42199345 — cells, mycosis fungoides, sezary syndrome, neoplasms, histones, precision medicine
Front Cell Dev Biol20260
Mycosis fungoides/Sézary syndrome and systemic Janus kinase inhibitors: a real-world retrospective study on behalf of the EORTC-CLTG.
PMID 41802918 — syphilis, mycosis fungoides, sezary syndrome, retrospective studies, janus kinases, janus kinase inhibitors, dermatology
Br J Dermatol20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1

By status:

Completed 2
Recruiting 1

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map